PATENT CLAIM ANALYSIS

Application Number: 16269146
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["546", "159000"]

Abstract:
Compounds and compositions for selectively inhibiting Akt3 are provided. Methods of using the compounds are also provided. Because Akt3 modulates the suppressive function of natural Tregs and the polarization of induced Tregs, the disclosed compounds are useful for modulating immune responses.

Claim (Index 2):
A pharmaceutical composition comprising one or more of the compounds of  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.5
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15407600', '15407659', '15900077', '14689517', '14679497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.794850107653951
- 35 USC 102 Novelty (BERT): 0.6275526044641374
- Combined Prediction Score: 0.7781203573349698
- Mean Citation Score: 478.527102
- Max Citation Score: 603.2253400000002
- Similarity Product: 552.9704163390401

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test